Proteome Sciences plc

Proteome Sciences plc

0.01
USD
+0.00
(-10.40%)
11.25MMarket Cap

Total Valuation

USD

As of December 31, 2025, Proteome Sciences PLC carries a market capitalization of 11.25M, placing it among publicly traded companies globally. Its enterprise value stands at 31.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap11.25M
Enterprise Value31.45M

Share Statistics

As of December 31, 2025, Proteome Sciences PLC has 295.18M shares outstanding.

Shares Outstanding295.18M

Valuation Ratios

These figures are as of December 31, 2025.

PB Ratio-0.88
P/TBV Ratio-0.61

Financial Position

As of December 31, 2025, Proteome Sciences PLC maintains a current ratio of 0.13, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.

Current Ratio0.13
Quick Ratio0.05
Debt / Equity-165.46

Financial Efficiency

These figures cover the twelve months ended December 31, 2025.

Employee Count34.00

Stock Price Statistics

USD

As of the close on September 2, 2026, Proteome Sciences PLC's stock has declined approximately 75.06% over the past 52 weeks.

52-Week Price Change-75.06%
50-Day Moving Average0.04

Balance Sheet

USD

As of December 31, 2025, Proteome Sciences PLC holds 1.05M in cash and equivalents against 21.25M in total debt, resulting in a net debt position of 18.43M. Total book value stands at -12.84M, with working capital of -19.53M providing operational flexibility.

Cash & Cash Equivalents1.05M
Total Debt21.25M
Net Debt18.43M
Equity (Book Value)-12.84M
Book Value Per Share-0.04
Working Capital-19.53M

Stock Splits

Proteome Sciences PLC's most recent stock split took place on June 11, 2010.

Last Split Date6/11/2010